About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Spyre Therapeutics, Inc. (SYRE): Insider Trades and Fund Holdings
In the past 12 months, Spyre Therapeutics, Inc. insiders reported no open-market purchases and 19 sales worth $422.6M; 17 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 7, 2026NewsCompany reported: Signed a material agreement
- Oct 1, 2026Insider saleSee Remarks Heidy King-Jones sold $2.6 million under a 10b5-1 plan
- Oct 1, 2026Insider saleCEO Cameron Turtle sold $1.4 million under a 10b5-1 plan
- Oct 1, 2026Insider saleCFO Scott L. Burrows sold $688,756 under a 10b5-1 plan
- Oct 1, 2026Planned saleCAMERON TURTLE (director, officer) filed notice to sell about $4 million around Oct 1, 2026
- Oct 1, 2026Planned saleHEIDY KING-JONES (officer) filed notice to sell about $2.6 million around Oct 1, 2026
- Sep 30, 2026Insider saleCFO Scott L. Burrows sold $1.6 million under a 10b5-1 plan
- Sep 30, 2026Planned saleSCOTT BURROWS (officer) filed notice to sell about $1.6 million around Sep 30, 2026
- Sep 2, 2026Insider saleCFO Scott L. Burrows sold $1.6 million under a 10b5-1 plan
- Sep 2, 2026Insider saleSee Remarks Heidy King-Jones sold $36,000 under a 10b5-1 plan
- Sep 1, 2026Insider saleSee Remarks Heidy King-Jones sold $2.4 million under a 10b5-1 plan
- Sep 1, 2026Insider saleCEO Cameron Turtle sold $1.3 million under a 10b5-1 plan
- Sep 1, 2026Insider saleCFO Scott L. Burrows sold $654,791 under a 10b5-1 plan
- Sep 1, 2026Planned saleHEIDY KING-JONES (officer) filed notice to sell about $4.2 million around Sep 1, 2026
- Aug 7, 2026Insider saleDirector Jeffrey W. Albers sold $2.4 million under a 10b5-1 plan (3 days after: quarterly or annual results)
- Aug 7, 2026Planned saleSESSIONS, LLC (director) filed notice to sell about $1.9 million around Aug 7, 2026
- Aug 7, 2026Planned saleJEFFREY ALBERS (director) filed notice to sell about $517,100 around Aug 7, 2026
- Aug 4, 2026NewsCompany reported: Quarterly or annual results
- Aug 3, 2026Insider saleCEO Cameron Turtle sold $1.4 million under a 10b5-1 plan
- Aug 3, 2026Insider saleCFO Scott L. Burrows sold $716,771 under a 10b5-1 plan
- Aug 3, 2026Planned saleSCOTT BURROWS (officer) filed notice to sell about $2.9 million around Aug 3, 2026
- Jul 1, 2026Insider saleCEO Cameron Turtle sold $1.3 million under a 10b5-1 plan
- Jul 1, 2026Insider saleChief Medical Officer Sheldon Sloan sold $730,896 under a 10b5-1 plan
- Jul 1, 2026Insider saleCFO Scott L. Burrows sold $658,039 under a 10b5-1 plan
- Jun 25, 2026Insider saleCFO Scott L. Burrows sold $1.3 million
- Jun 23, 2026Insider saleDirector Fairmount Funds Management LLC sold $399.7 million
- Jun 22, 2026Insider saleDirector Michael Thomas Henderson sold $2 million under a 10b5-1 plan
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 2 | Heidy King-JonesSee Remarks | ▼ SELL10b5-1 | $2.63M |
| Oct 2 | Scott L. BurrowsCFO | ▼ SELL10b5-1 | $1.57M |
| Oct 2 | Cameron TurtleCEO | ▼ SELL10b5-1 | $1.38M |
| Oct 2 | Scott L. BurrowsCFO | ▼ SELL10b5-1 | $689K |
| Sep 3 | Heidy King-JonesSee Remarks | ▼ SELL10b5-1 | $2.44M |
| Sep 3 | Scott L. BurrowsCFO | ▼ SELL10b5-1 | $1.63M |
| Sep 3 | Cameron TurtleCEO | ▼ SELL10b5-1 | $1.31M |
| Sep 3 | Scott L. BurrowsCFO | ▼ SELL10b5-1 | $655K |
| Sep 3 | Heidy King-JonesSee Remarks | ▼ SELL10b5-1 | $36K |
| Aug 10 | Jeffrey W. AlbersDirector | ▼ SELL10b5-1 | $1.88M |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Heidy King-Jones | See Remarks | 0 | $0 | 3 | $5.11M |
| Scott L. Burrows | CFO | 0 | $0 | 7 | $7.23M |
| Cameron Turtle | CEO | 0 | $0 | 4 | $5.44M |
| Jeffrey W. Albers | Director | 0 | $0 | 2 | $2.40M |
| Sheldon Sloan | Chief Medical Officer | 0 | $0 | 1 | $731K |
| Fairmount Funds Management LLC | Director | 0 | $0 | 1 | $399.7M |
| Michael Thomas Henderson | Director | 0 | $0 | 1 | $2.00M |
A All 19 insider trades reported on time. How it is graded
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →